Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against Stevanato Group, S.p.A.. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Why Is Stevanato Group, S.p.A. (STVN) Under Investigation?
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of shareholders of Stevanato Group, S.p.A. (NYSE: STVN).
On November 3, 2026, Stevanato reported its third-quarter 2026 financial results and disclosed that revenue from GLP-1 therapies accounted for approximately 17% to 18% of total revenue for the quarter. The Company stated that it expected lower GLP-1 volumes and revenue than previously anticipated, tied to one customer, and that the reduction would temporarily moderate growth in 2027. Stevanato stated that it expected low-single-digit growth in 2027. Following this news, Stevanato’s stock price fell $5.64 per share, or 28.57%, to close at $14.10 on November 3, 2026.
What Potential Securities Violations Is BG&G Investigating?
- Whether Stevanato Group, S.p.A. and certain of its officers made false or misleading statements regarding the Company's financial condition and business prospects.
- Whether Stevanato Group, S.p.A. failed to disclose material adverse information that would have been significant to a reasonable investor.
- Whether the Company's earnings guidance was supported by a reasonable factual basis at the time it was made.
What Should Stevanato Group, S.p.A. (STVN) Investors Do?
How Is Stevanato Group, S.p.A. (NYSE: STVN) Stock Trading Today?
Interactive chart showing the weekly share price history of NYSE:STVN (NYSE:STVN).
How Does BG&G Help Investors in Securities Fraud Investigations?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
We handle cases on a contingency fee basis — we advance all litigation costs on your behalf. There is no fee unless we are successful.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”